Screener
Neurocrine Biosciences NBIX Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Neurocrine Biosciences’s reported figures.
Based on the most recent quarter.
The source filing: Neurocrine Biosciences’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000914475-26-000026
FAQ
- What is Neurocrine Biosciences's book value per share?
- Neurocrine Biosciences (NBIX) reported book value per share of $32.95 in Q1 2026.
- How has Neurocrine Biosciences's book value per share changed year-over-year?
- Neurocrine Biosciences's book value per share increased by 33.2% year-over-year, from $24.74 to $32.95.
- What is the long-term trend for Neurocrine Biosciences's book value per share?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's book value per share has grown at a 22.3% compound annual growth rate (CAGR), from $11.59 to $31.74.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Neurocrine Biosciences's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude